E. Ohman J:Or Asset Management Ab Biogen Inc. Transaction History

E. Ohman J:Or Asset Management Ab

  • $4.04 Trillion
  • Q3 2024

A detailed history of E. Ohman J:Or Asset Management Ab transactions in Biogen Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 5,599 shares of BIIB stock, worth $884,082. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,599
Previous 6,099 8.2%
Holding current value
$884,082
Previous $1.41 Billion 23.24%
% of portfolio
0.03%
Previous 0.04%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$189.07 - $236.8 $94,535 - $118,400
-500 Reduced 8.2%
5,599 $1.09 Billion
Q2 2024

Aug 13, 2024
SELL
$190.52 - $236.72 $3.43 Million - $4.26 Million
-18,000 Reduced 74.69%
6,099 $1.41 Billion
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $3.92 Million - $4.95 Million
18,500 Added 330.42%
24,099 $5.2 Billion
Q4 2023

Feb 15, 2024
SELL
$222.59 - $267.94 $200,331 - $241,146
-900 Reduced 13.85%
5,599 $1.45 Billion
Q3 2023

Feb 06, 2024
BUY
$253.3 - $285.89 $1.65 Million - $1.86 Million
6,499 New
6,499 $1.67 Billion
Q2 2023

Apr 05, 2024
BUY
$275.25 - $318.06 $165,150 - $190,836
600 Added 9.53%
6,899 $1.97 Billion
Q3 2022

Apr 05, 2024
SELL
$194.69 - $268.46 $136,283 - $187,922
-700 Reduced 10.0%
6,299 $1.68 Billion
Q3 2021

Apr 05, 2024
BUY
$282.99 - $369.05 $226,392 - $295,240
800 Added 12.91%
6,999 $1.98 Billion
Q1 2021

Apr 05, 2024
SELL
$242.95 - $284.63 $48,590 - $56,926
-200 Reduced 3.13%
6,199 $1.73 Billion
Q4 2020

Apr 05, 2024
SELL
$236.26 - $355.63 $118,130 - $177,815
-500 Reduced 7.25%
6,399 $1.57 Billion
Q3 2020

Apr 05, 2024
SELL
$264.77 - $305.71 $52,954 - $61,141
-200 Reduced 2.82%
6,899 $1.96 Billion
Q2 2020

Apr 05, 2024
BUY
$258.66 - $342.55 $129,330 - $171,275
500 Added 7.58%
7,099 $1.9 Billion
Q1 2020

Apr 05, 2024
SELL
$268.85 - $341.04 $752,780 - $954,912
-2,800 Reduced 29.79%
6,599 $2.09 Billion
Q4 2019

Apr 05, 2024
BUY
$220.06 - $304.07 $109,809 - $151,730
499 Added 5.61%
9,399 $2.79 Billion
Q3 2019

Apr 05, 2024
BUY
$217.44 - $243.88 $108,720 - $121,940
500 Added 5.95%
8,900 $2.07 Billion
Q2 2019

Apr 05, 2024
SELL
$219.29 - $241.72 $9.32 Million - $10.3 Million
-42,498 Reduced 83.5%
8,400 $1.96 Billion
Q1 2019

Apr 05, 2024
SELL
$216.71 - $338.96 $2.26 Million - $3.54 Million
-10,438 Reduced 17.02%
50,898 $12 Billion
Q4 2018

Apr 05, 2024
BUY
$278.5 - $352.75 $2.76 Million - $3.5 Million
9,918 Added 19.29%
61,336 $18.5 Billion
Q3 2018

Apr 05, 2024
SELL
$293.51 - $383.83 $2.68 Million - $3.51 Million
-9,135 Reduced 15.09%
51,418 $18.2 Billion
Q2 2018

Apr 05, 2024
BUY
$257.52 - $306.91 $2.99 Million - $3.56 Million
11,592 Added 23.68%
60,553 $17.6 Billion
Q1 2018

Apr 05, 2024
SELL
$260.13 - $367.91 $48,904 - $69,167
-188 Reduced 0.38%
48,961 $13.4 Billion
Q4 2017

Apr 05, 2024
BUY
$307.64 - $344.58 $1.03 Million - $1.16 Million
3,363 Added 7.35%
49,149 $15.7 Billion
Q3 2017

Apr 05, 2024
BUY
$281.15 - $329.69 $26,990 - $31,650
96 Added 0.21%
45,786 $14.3 Billion
Q2 2017

Apr 05, 2024
BUY
N/A
23,267 Added 103.76%
45,690 $12.4 Billion
Q1 2017

Apr 05, 2024
BUY
N/A
2,970 Added 15.27%
22,423 $6.13 Billion
Q4 2016

Apr 05, 2024
BUY
N/A
1,488 Added 8.28%
19,453 $5.52 Billion
Q3 2016

Apr 05, 2024
BUY
N/A
13,665 Added 317.79%
17,965 $5.62 Billion
Q3 2015

Apr 05, 2024
SELL
N/A
-600 Reduced 12.24%
4,300 $1.25 Billion
Q2 2015

Apr 05, 2024
SELL
N/A
-400 Reduced 7.55%
4,900 $1.98 Billion
Q1 2014

Apr 05, 2024
SELL
N/A
-700 Reduced 11.67%
5,300 $1.62 Billion
Q4 2013

Apr 05, 2024
SELL
N/A
-200 Reduced 3.23%
6,000 $1.68 Billion
Q3 2013

Apr 05, 2024
BUY
N/A
400 Added 6.9%
6,200 $1.49 Billion
Q4 2012

Apr 05, 2024
BUY
N/A
400 Added 7.41%
5,800 $849 Million
Q3 2012

Apr 05, 2024
SELL
N/A
-500 Reduced 8.47%
5,400 $806 Million
Q1 2012

Apr 05, 2024
BUY
N/A
1,200 Added 25.53%
5,900 $743 Million
Q4 2011

Apr 05, 2024
SELL
N/A
-500 Reduced 9.62%
4,700 $517 Million
Q1 2011

Apr 05, 2024
BUY
N/A
1,000 Added 23.81%
5,200 $381 Million
Q1 2010

Apr 05, 2024
BUY
N/A
1,000 Added 31.25%
4,200 $241 Million
Q4 2009

Apr 05, 2024
SELL
N/A
-1,500 Reduced 31.91%
3,200 $171 Million
Q2 2009

Apr 05, 2024
BUY
N/A
1,300 Added 38.24%
4,700 $212 Million
Q3 2008

Apr 05, 2024
SELL
N/A
-1,500 Reduced 30.61%
3,400 $171 Million
Q2 2008

Apr 05, 2024
BUY
N/A
1,700 Added 53.13%
4,900 $274 Million
Q4 2006

Apr 05, 2024
SELL
N/A
-2,399
3,200 $157 Million

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email